The Division of Transplantation has earned acclaim from the international medical community for such breakthroughs as the Belzer-UW solution for organ preservation, research and clinical trials into the immunosuppressive drug Mycophenolate Mofetil, and improved surgical techniques for pancreas transplantation.
Current laboratory research includes programs in organ preservation, the development of new immunosuppressants, gene therapy for diabetes as an alternative to pancreas transplantation, xenotransplantation, normothermic machine perfusion, and induction of immunological tolerance to organ transplantation as an alternative to lifelong immunosuppression.
Active Transplant Clinical Trials
The Transplant Clinical Trials Office can be contacted at (608) 263-2565.